JP2016013980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016013980A5 JP2016013980A5 JP2014135762A JP2014135762A JP2016013980A5 JP 2016013980 A5 JP2016013980 A5 JP 2016013980A5 JP 2014135762 A JP2014135762 A JP 2014135762A JP 2014135762 A JP2014135762 A JP 2014135762A JP 2016013980 A5 JP2016013980 A5 JP 2016013980A5
- Authority
- JP
- Japan
- Prior art keywords
- film
- coated tablet
- tablet according
- light
- coating layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007941 film coated tablet Substances 0.000 claims 5
- 239000010410 layer Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000007888 film coating Substances 0.000 claims 3
- 238000009501 film coating Methods 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 150000007514 bases Chemical class 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 239000005537 C09CA07 - Telmisartan Substances 0.000 claims 1
- 235000014852 L-arginine Nutrition 0.000 claims 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N Meglumine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 1
- 229960003194 Meglumine Drugs 0.000 claims 1
- RMMXLENWKUUMAY-UHFFFAOYSA-N Telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 claims 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive Effects 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229960003943 hypromellose Drugs 0.000 claims 1
- 229960005187 telmisartan Drugs 0.000 claims 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical group O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 1
- 229910001929 titanium oxide Inorganic materials 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014135762A JP6440294B2 (ja) | 2014-07-01 | 2014-07-01 | テルミサルタン含有フィルムコーティング錠剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014135762A JP6440294B2 (ja) | 2014-07-01 | 2014-07-01 | テルミサルタン含有フィルムコーティング錠剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016013980A JP2016013980A (ja) | 2016-01-28 |
| JP2016013980A5 true JP2016013980A5 (hr) | 2017-07-13 |
| JP6440294B2 JP6440294B2 (ja) | 2018-12-19 |
Family
ID=55230496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014135762A Active JP6440294B2 (ja) | 2014-07-01 | 2014-07-01 | テルミサルタン含有フィルムコーティング錠剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6440294B2 (hr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6132858B2 (ja) * | 2015-01-09 | 2017-05-24 | ダイト株式会社 | テルミサルタン含有フィルムコート錠 |
| JP2020094024A (ja) * | 2018-12-14 | 2020-06-18 | エルメッド株式会社 | レベチラセタム含有フィルムコート錠及びその製造方法、並びにレベチラセタム含有フィルムコート錠の変色抑制方法 |
| JP7262005B2 (ja) * | 2019-01-25 | 2023-04-21 | 日本ジェネリック株式会社 | シロドシン含有固形組成物及びその製造法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4016128B2 (ja) * | 1999-09-09 | 2007-12-05 | 東和薬品株式会社 | 耐光性塩酸エピナスチンフィルムコート錠 |
| DE10244681A1 (de) * | 2002-09-24 | 2004-04-08 | Boehringer Ingelheim International Gmbh | Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung |
| JP3496832B1 (ja) * | 2002-12-27 | 2004-02-16 | 小野薬品工業株式会社 | コーティング製剤およびその製造方法 |
| JP4675751B2 (ja) * | 2005-11-04 | 2011-04-27 | 東和薬品株式会社 | アムロジピンを含有する安定化された医薬品組成物 |
| JPWO2008114859A1 (ja) * | 2007-03-22 | 2010-07-08 | アステラス製薬株式会社 | ピラゾール誘導体を含有する医薬組成物 |
| EP2612658A1 (en) * | 2012-01-05 | 2013-07-10 | Laboratorios Lesvi, S.L. | Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
-
2014
- 2014-07-01 JP JP2014135762A patent/JP6440294B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015078230A5 (hr) | ||
| EP3328843A4 (en) | 1,3,4-OXADIAZOLSULFONAMID DERIVATIVE COMPOUNDS AS A HISTONDEACETYLASE INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| JP2017509667A5 (hr) | ||
| JP2015147774A5 (hr) | ||
| JP2015057451A5 (hr) | ||
| AR122580A2 (es) | Forma de dosificación de doxilamina y piridoxina y/o sus metabolitos o sales | |
| JP2014218522A5 (hr) | ||
| EA201792290A1 (ru) | Таблетка, содержащая рибоциклиб | |
| RS54238B1 (en) | ORAL FILM FORMULATIONS CONTAINING DAPOXETINE AND TADALAFIL | |
| EP3763815A4 (en) | THERAPEUTIC AGENT FOR GLYCOGEN STORAGE DISEASE TYPE IA | |
| JP2016013980A5 (hr) | ||
| AR092356A1 (es) | Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion | |
| JP2018118936A5 (hr) | ||
| JP2015508411A5 (hr) | ||
| JP2016033133A5 (hr) | ||
| NZ611026A (en) | Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria | |
| EP3530654A4 (en) | CARBOXYLIC ACID COMPOUND WITH QUINOLINYL SUBSTITUTE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| JP2016507627A5 (hr) | ||
| JP2015221782A5 (hr) | ||
| JP2016513680A5 (hr) | ||
| ECSP16005208A (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
| WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
| JP2019518052A5 (hr) | ||
| JP2019526545A5 (hr) | ||
| JP2018002699A5 (hr) |